Use este identificador para citar ou linkar para este item: http://repositorio.ufla.br/jspui/handle/1/46366
Título: Treatment of primate platynosomosis: a word of caution about the use of praziquantel in marmosets
Palavras-chave: Callithrix penicillata
Neotropical primates
Primates - Platynosomiasis
Platynosomum illiciens - Treatment
Praziquantel
Primatas neotropicais
Primatas - Platinossomíase
Platynosomum illiciens - Tratamento
Data do documento: Fev-2021
Editor: John Wiley & Sons
Citação: MATI, V. L. T.; PINTO, H. A.; MELO, A. L. de. Treatment of primate platynosomosis: a word of caution about the use of praziquantel in marmosets. Journal of Medical Primatology, Copenhagen, v. 50, n. 1, p. 60-66, Feb. 2021.
Resumo: Background The successive reports of Platynosomum illiciens in Neotropical captive primates have increased interest in platynosomosis; however, its treatment is little known. Methods Callithrix penicillata (n = 10) naturally and chronically infected with P. illiciens were treated with praziquantel (25 mg/kg BW, three s.c. doses at 24 hours intervals), and coproparasitological tests performed over 67 days. The proportions of primates with a reduction in fecal egg counts (FEC) or negative results progressively increased after treatment, and at the last fecal tests, marmosets were negative. Results and Conclusions Although all primates tolerated the initial days of study well, 40% (4/10) of them died between the 8th and 16th days after the onset of treatment. Clinical signs and necropsies indicated the occurrence of hepatic involvement, biliary obstruction, and cholangitis. Marmosets with a higher previous FEC were more likely to die after treatment. Use of praziquantel should be considered carefully on a case-by-case basis.
URI: https://doi.org/10.1111/jmp.12503
http://repositorio.ufla.br/jspui/handle/1/46366
Aparece nas coleções:DME - Artigos publicados em periódicos

Arquivos associados a este item:
Não existem arquivos associados a este item.


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.